Internal Medicine · Durham, NC
NPI
1235227844
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
Campus Box 3841, Dumc
Durham, NC, 27710
Phone (919) 684-8111
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
373 services
Medicare patients, 2024
131
Average age 71
Drug cost, 2024
$777K
311 prescriptions
Company payments, 2025
$47K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard F Riedel was code 99214 (office e&m - established), 86 times for 50 patients. In total Richard F Riedel billed 373 services in 11 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 86 | 50 | $63.79 | $5,486 |
| 99215 Office E&M - Established | Facility | 81 | 39 | $97.57 | $7,903 |
| 99213 Office E&M - Established | Facility | 68 | 49 | $43.35 | $2,948 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 68 | 33 | $11.78 | $801 |
| 99205 Office E&M - New | Facility | 20 | 20 | $128.06 | $2,561 |
By year: 2022 $31K for 385 services; 2023 $26K for 325 services; 2024 $24K for 373 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard F Riedel prescribed most often to Medicare patients was Imatinib Mesylate, with 93 prescriptions and refills. In total Richard F Riedel wrote 311 Medicare prescriptions that cost $777K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 93 | 93 | 13 | $56K |
| Prochlorperazine Maleate Generic | 32 | 32 | 20 | $371 |
| Pazopanib Hcl Generic | 28 | 28 | Under 11 | $261K |
| Oxycodone Hcl Generic | 13 | 13 | Under 11 | $309 |
| Sirolimus Generic | 11 | 11 | Under 11 | $1,189 |
Brand drugs: 36 claims; generic drugs: 275 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard F Riedel $47K ($47K in general payments such as food, travel and fees) from 11 companies. The largest payer was SpringWorks Therapeutics, Inc. with $15K.
| Company | Payments | Amount |
|---|---|---|
| SpringWorks Therapeutics, Inc. | 18 | $15K |
| Daiichi Sankyo Inc. 4568.T | 11 | $8,004 |
| Recordati_rare_diseases_inc. | 7 | $7,111 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $5,460 |
| EMD Serono, Inc. MRK.DE | 1 | $4,275 |
| EMD Serono Research & Development Institute, Inc. MRK.DE | 1 | $3,800 |
| Deciphera Pharmaceuticals Inc. | 5 | $3,060 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $68.49 |
| Servier BioInnovation | 1 | $64.84 |
| GlaxoSmithKline, LLC. GSK | 1 | $49.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.